Target intelligence / Profile preview

Probable ATP-dependent RNA helicase DDX53 (DDX53)

Target
DDX53
Molecular classification
Enzyme, RNA helicase, DEAD-box protein family
01

Overview

Probable ATP-dependent RNA helicase DDX53 (DDX53) is a member of the DEAD-box RNA helicase family, characterized by its ability to unwind RNA in an ATP-dependent manner. It contains several domains common to other DEAD-box proteins, is encoded by an intronless gene on the human X chromosome, and is primarily expressed in cancer cells. DDX53 has been implicated in tumorigenesis through interactions with microRNAs and histone deacetylases, and is associated with stem cell-like properties, autophagy, and resistance to anti-cancer drugs. It may serve as a biomarker for certain cancers (notably breast adenocarcinoma) and has also been linked to Autism Spectrum Disorder. The 3D molecular structure has recently been elucidated, providing a basis for structure-based drug design targeting its helicase domain for cancer therapy.

Other names
DDX53CAGECT26Cancer-associated gene proteinCancer/testis antigen 26DEAD-box helicase 53DEAD-box protein CAGEDEAD (Asp-Glu-Ala-Asp) box polypeptide 53
02

Mechanism of action

Inhibition of ATP-dependent RNA helicase activity, interference with RNA metabolic processes central to cell proliferation and survival

03

Biological functions

RNA unwindingRNA processingnucleic acid bindingATP-dependent helicase activityinteraction with microRNA and histone deacetylasespromotion of stem cell-like propertiesautophagydrug resistance in cancer cells
04

Disease associations

Cancer (tumorigenesis, breast adenocarcinoma)Autism Spectrum Disorder
05

Safety considerations

Drug resistance in cancer (when DDX53 is upregulated)potential off-target effects due to fundamental role in RNA metabolism in normal cells
06

Biomarkers

Overexpression in cancer cells (biomarker for cancer/testis family antigens)potential relevance in patient selection for targeted anti-cancer therapies

Beyond the preview

Go deeper on Probable ATP-dependent RNA helicase DDX53 (DDX53).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable ATP-dependent RNA helicase DDX53 (DDX53).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call